Department of Pathology, Medical Faculty, Otto-von-Guericke-University, Magdeburg, Germany.
FEBS Lett. 2021 Dec;595(24):3072-3082. doi: 10.1002/1873-3468.14230. Epub 2021 Nov 22.
Interleukin-6 (IL-6) and interleukin-11 (IL-11) are two important pleiotropic cytokines, both of which signal through a homodimer of the β-receptor gp130. Specificity is gained through the unique, nonsignaling α-receptors IL-6R and IL-11R. Soluble variants of IL-6R and IL-11R also exist. Both membrane-bound receptors can be cleaved by the metalloprotease ADAM10. Here, we use ten different chimeric receptors consisting of different parts of IL-6R and IL-11R and analyze their susceptibility toward cleavage by ADAM10. As expected, all chimeras are substrates of ADAM10. However, we observed that cleavage of chimeric receptors containing the stalk region of the IL-11R could be blocked by the protease inhibitor GI (selective for ADAM10), but not by the protease inhibitor GW (selective for both ADAM10 and ADAM17), suggesting that another protease besides ADAM10 is involved in cleavage of these chimeras.
白细胞介素-6(IL-6)和白细胞介素-11(IL-11)是两种重要的多功能细胞因子,它们都通过β-受体 gp130 的同源二聚体信号传导。特异性是通过独特的、无信号的α-受体 IL-6R 和 IL-11R 获得的。IL-6R 和 IL-11R 的可溶性变体也存在。两种膜结合受体都可以被金属蛋白酶 ADAM10 切割。在这里,我们使用由 IL-6R 和 IL-11R 的不同部分组成的十个不同的嵌合受体,并分析它们对 ADAM10 切割的敏感性。正如预期的那样,所有嵌合体都是 ADAM10 的底物。然而,我们观察到,包含 IL-11R 茎部区域的嵌合受体的切割可以被蛋白酶抑制剂 GI(选择性针对 ADAM10)阻断,但不能被蛋白酶抑制剂 GW(选择性针对 ADAM10 和 ADAM17)阻断,这表明除了 ADAM10 之外,还有另一种蛋白酶参与了这些嵌合体的切割。